China approves use of Pfizer’s COVID drug Paxlovid
BEIJING (Reuters) -China’s medical products regulator said on Saturday it has given conditional approval for Pfizer (NYSE:PFE)’s COVID-19 drug Paxlovid, making it the first oral pill specifically developed to treat the disease.